Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - UNAUDITED

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - UNAUDITED - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Paid-in Capital
Retained Earnings/(Accumulated Deficit)
Accumulated Other Comprehensive Loss
Noncontrolling interest
Balance at beginning of period at Dec. 31, 2020 $ 212,838 $ 0 $ 152 $ 203,463 $ 9,354 $ (131) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (20,021)       (13,572)   (6,449)
Issuance of preferred stock 2 2          
Issuance of Noncontrolling interest 179,552     (50,068)     229,620
All other changes [1] 1,772   1 1,769   1 1
Balance at end of period at Mar. 31, 2021 374,143 2 153 155,164 (4,218) (130) 223,172
Balance at beginning of period at Dec. 31, 2021 669,508 0 731 273,329 49,583 (111) 345,976
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (20,661)       (9,985)   (10,676)
All other changes [2] 478     478      
Balance at end of period at Mar. 31, 2022 $ 649,325 $ 0 $ 731 $ 273,807 $ 39,598 $ (111) $ 335,300
[1] Includes equity-classified share-based compensation of $2.2 million during the three months ended March 31, 2021. During the three months ended March 31, 2021, 102,586 and 6,800 shares of common stock were issued in connection with the vesting of certain RSUs and PRSUs, net of shares withheld for income taxes, respectively.
[2] Includes equity-classified share-based compensation of $0.9 million during the three months ended March 31, 2022. During the three months ended March 31, 2022, 69,206 of common stock were issued in connection with the vesting of certain time-vested restricted stock units (“RSUs”), net of shares withheld for income taxes. No shares of common stock were issued in connection with the vesting of performance-based restricted stock units (“PRSUs”) during the three months ended March 31, 2022.